CHRIS LUCAS TRUST
The trust raises money to provide funding for the employment of a scientific researcher to carry out research into rhabdomyosarcoma, and provides counselling and advice.
Financial health, per its FY2025 accounts
The accounts state that the charity generated a net surplus of £1,721 for the year, bringing total unrestricted funds to £43,952. The trustees report adequate resources to continue in operational existence for the foreseeable future, confirming the going concern basis. The charity holds cash reserves of £44,782 at the year end to help fund future research grants.
What the accounts disclose
Funders the charity credits
- Institute of Cancer Research
- Royal Marsden Hospital
Trustees
- EILEEN GILESchair
- BRIAN GILES
- DONNA BAKER FORSTER
- MOYRA ALICE ANN MACKEY
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £95k | £94k |
| 31/03/2024 | £86k | £96k |
| 31/03/2023 | £110k | £116k |
| 31/03/2022 | £113k | £142k |
| 31/03/2021 | £68k | £44k |
Common questions
Is CHRIS LUCAS TRUST financially healthy?
Per its FY2025 accounts: The accounts state that the charity generated a net surplus of £1,721 for the year, bringing total unrestricted funds to £43,952. The trustees report adequate resources to continue in operational existence for the foreseeable future, confirming the going concern basis. The charity holds cash reserves of £44,782 at the year end to help fund future research grants. Its FY2025 accounts were independently examined.